Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05513833 · ClinicalTrials.gov registry record · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
A NA study of Hearing Loss, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 18,000
- Enrollment target
- 1
- Study location
NCT05513833: Recruiting NA study of Hearing Loss, sponsored by University of Arkansas.
NCT05513833 is a NA study of Hearing Loss that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 18,000 participants, above the 5,811-participant average among 58 other Hearing Loss trials with a reported enrollment target (210% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05513833, a NA study of Hearing Loss, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 18,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will evaluate a multilevel intervention (STAR model) that combines mobile health (mHealth) hearing screening tools with telemedicine technology for specialty care access in rural Kentucky schools. An initial version of the model was used in rural Alaska where telemedicine-based specialty referral improved both proportion of children receiving follow-up and time to follow-up. The refined STAR model will utilize an enhanced mHealth screening protocol that includes tympanometry for the detection of middle ear disease. The STAR model will also include a specialty telemedicine referral process in schools for children who refer school screening.
Primary Outcome
This outcome will be measured at the end of each annual screening period for each school, for 5 years, based on the updated timeline.
Conditions Studied
Interventions
- OTHER Standard School Screening and Referral
- OTHER Enhanced mHealth Screening
- OTHER Specialty Telemedicine Referral
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,000 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05513833 shows while recruiting
NCT05513833 is an interventional study that assigns participants to a tested intervention. Its 18,000 participants enrollment target places it among the larger protocols in the corpus, above the 5,811-participant average among 58 other Hearing Loss trials with a reported enrollment target (210% higher).
The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 3 interventions - of which Standard School Screening and Referral is the first listed.
NCT05513833 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05513833 about?
NCT05513833 is a clinical study titled "School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky". This trial will evaluate a multilevel intervention (STAR model) that combines mobile health (mHealth) hearing screening tools with telemedicine technology for specialty care access in rural Kentucky schools. An initial version of the model was used in rural Alaska where telemedicine-based specialty ...
What is the current status of trial NCT05513833?
This trial is currently recruiting. It is a NA study. The enrollment target is 18,000 participants. The study started on 2022-09-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05513833 study?
This clinical trial studies the following conditions: Hearing Loss.
What interventions are being tested in trial NCT05513833?
The interventions under investigation include: Standard School Screening and Referral (OTHER), Enhanced mHealth Screening (OTHER), Specialty Telemedicine Referral (OTHER).
Who is sponsoring clinical trial NCT05513833?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05513833 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05513833's enrollment target sits among peer trials
18,000 2nd of 58 the highest of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI